Edoc Acquisition Corp.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ADOC research report →
Companyedocmed.net
Edoc Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses primarily in the health care and health care provider space in North America and the Asia-Pacific.
- CEO
- Kevin Chen
- IPO
- 2020
- HQ
- Victor, NY, US
Price Chart
Valuation
- Market Cap
- $10.32M
- P/E
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -1.60
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -14.30%
- ROIC
- -13.21%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-7,686,000 · -754.11%
- EPS
- $-0.00 · -1200.00%
- Op Income
- $-2,545,000
- FCF YoY
- -87.78%
Performance & Tape
- 52W High
- $11.96
- 52W Low
- $2.50
- 50D MA
- $9.89
- 200D MA
- $11.01
- Beta
- -0.11
- Avg Volume
- 22.08K
Get TickerSpark's AI analysis on ADOC
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 15, 23 | Yakira Capital Management, Inc. | other | 248,622 |
| Aug 12, 22 | Yakira Capital Management, Inc. | other | 70,605 |
| Aug 12, 22 | Yakira Capital Management, Inc. | other | 0 |
| Oct 12, 22 | Li Yan Michael | other | 0 |
| Oct 12, 22 | Li Yan Michael | other | 0 |
| Oct 12, 22 | Zheng Jintao | other | 0 |
| Oct 12, 22 | Zheng Jintao | other | 0 |
| Dec 24, 20 | Zhang Xiaoping Becky | other | 337,500 |
| Dec 24, 20 | American Physicians LLC | other | 337,500 |
| Nov 12, 20 | American Physicians LLC | buy | 414,000 |
Our ADOC Coverage
We haven't published any research on ADOC yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ADOC Report →